TrialWorld journal of gastroenterology2021

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.

Maria Nadinskaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.